ASCO 2023 - American Society of Clinical Oncology (ASCO) Annual Meeting Date: June 2-6, 2023 Venue: McCormick Place • Chicago, Illinois, United States + Online (线上+线下) 会议日程: View theASCO Annual Meeting Program PDF版for Program information, Awards, the Industry Expert Theater schedu...
SCHEDULE A MEETING Meet us in Chicago atASCOJoin us in Chicago for the annual meeting for American Society of Clinical Oncology (ASCO) and be a part of the most significant gathering of oncology professionals worldwide with us. With a global oncology Real-World Data footprint spanning North Am...
With this experience, Novotech was proud to present “How to accelerate development in novel & advanced oncology therapies — from the starting line” webinar in collaboration with eChinaHealth and the ASCO 2023 committee last year. Schedule a meeting with our attendees...
The 2013 IDSA guideline notes that nonlive vaccines indicated for travel based on the CDC annual schedule for immunocompetent adults and children may be administered to immunosuppressed individuals, and that live agent vaccines generally should not ...
Preliminary efficacy data was presented at the 2023 AACR-NCI-EORTC meeting in October 2023 showing KB-0742’s on-mechanism anti-tumor activity in transcriptionally addicted tumors including a partial response at the 60mg three-days-on, four-days-off dose schedule. ...
推荐建议是在从2013年1月1日到2023年2月16日通过对PubMed和Cochrane图书馆进行在线搜索获得,并通过系统回顾证据进行制定的。这个系统回顾基于2013年美国传染病学会(IDSA)关于免疫功能受损宿主疫苗接种的指南5,并可能引用先前提供推荐证据基础且这些没有发表更新版本的文献。符合以下标准的文章被选入系统回顾: The recomm...
Yale Cancer Center and Smilow Cancer Hospital scientists and clinicians will present new research at the 2023 Annual Meeting of the American Society of Clinical Oncology, June 2nd to June 6th at McCormick Place in Chicago, Illinois.
Johnson & Johnson presentations at ASCO 2024 Annual Meeting: Lung Cancer Oral Presentations Abstract #8504 Amivantamab plus lazertinib vs osimertinib in first-line EGFR-mutant advanced non-small cell lung cancer (NSCLC) with biomarker...
Darcy Burbage, DNP, RN, AOCN, CBCN, shares which presentations from the 2023 ASCO Annual Meeting she found most important for oncology nurses.
Michael Bailey, president and chief executive officer of AVEO, stated, “We are pleased to present these three posters at this year’s ASCO Annual Meeting, which we believe further showcase the profile of tivozanib as an effective therapy for relapsed or refractory advanced (R/R) rena...